Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Accord Healthcare, Inc.

Accord Healthcare, Inc. Recalls

All product recalls associated with Accord Healthcare, Inc..

Get alerts for this brand

Recall Summary

Total Recalls

249

Past Year

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 41–60 of 249 recalls

Dodex Injectable (Accord) – Sub-potent Drug (2023)

Sub-potent drug: assay test result below specifications at 9-month timepoint.

Class IIILow

FDAMar 29, 2023Nationwide• Accord Healthcare, Inc.

Access Vascular, Inc: HydroPICC 4Fr Single Lumen Catheter, Maximal Barrier Kit,...

The catheter packaged with specific lots of the HydroPICC Kits and HydroMID Kits have a shorter expiration date than what is listed on the outer kit package.

FDAMar 3, 2023FL, TN, TX• Access Vascular, Inc

BusPIRone Hydrochloride Tablets 15 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Stay Informed

Accord Healthcare, Inc. Recalls

Recall Summary

Dodex Injectable (Accord) – Sub-potent Drug (2023)

Access Vascular, Inc: HydroPICC 4Fr Single Lumen Catheter, Maximal Barrier Kit,...

BusPIRone Hydrochloride Tablets 15 mg (Accord Healthcare) – Manufacturing Deviation (2023)

BusPIRone Hydrochloride 10mg (Accord Healthcare) – CGMP Issues (2023)

Phenylephrine Injection (Accord) - Manufacturing Deviation (2023)

Vigabatrin Oral Solution 500 mg (Accord Healthcare) – Manufacturing Deviation (2023)

Daptomycin for Injection 500 mg (Accord Healthcare) – CGMP Deviation (2023)

Pravastatin Sodium Tablets 80 mg (Accord Healthcare) – Manufacturing Deviation (2023)

Glycopyrrolate Injection 0.2mg/mL (Accord Healthcare) – CGMP Issues (2023)

Finasteride Tablets 5 mg (Accord Healthcare) – Manufacturing Deviation (2023)

Montelukast Sodium Tablets (Accord) - Manufacturing Deviation (2023)

Dofetilide Capsules 250 mcg (Accord Healthcare) – Manufacturing Deviation (2023)

rOPINIRole Tablets 0.5 mg (Accord Healthcare) – CGMP Deviation (2023)

Pirfenidone Tablets (Accord) - Manufacturing Deviation (2023)

Pravastatin Sodium Tablets 10 mg (Accord Healthcare) – Manufacturing Deviation (2023)

Atorvastatin Calcium Tablets (Accord) - Manufacturing Deviation (2023)

Doxazosin Tablets 1mg (Accord Healthcare) – CGMP Issues (2023)

Aripiprazole Tablets (Accord) - Manufacturing Deviation (2023)

Simvastatin Tablets 80 mg (Accord Healthcare) – Manufacturing Deviation (2023)

Glimepiride Tablets 4mg (Accord Healthcare) – CGMP Issues (2023)